Nuclear Coactivator-62 KDa/Ski-interacting Protein is a Nuclear Matrix-associated Coactivator That May Couple Vitamin D Receptor-mediated Transcription and RNA Splicing
Overview
Authors
Affiliations
Nuclear coactivator-62 kDa/Ski-interacting protein (NCoA62/SKIP) is a putative vitamin D receptor (VDR) and nuclear receptor coactivator protein that is unrelated to other VDR coactivators such as those in the steroid receptor coactivator (SRC) family. The mechanism through which NCoA62/SKIP functions in VDR-activated transcription is unknown. In the present study, we identified a nuclear localization sequence in the COOH terminus of NCoA62/SKIP and showed that NCoA62/SKIP was targeted to nuclear matrix subdomains. Chromatin immunoprecipitation studies revealed that endogenous NCoA62/SKIP associated in a 1,25-dihydroxyvitamin D3-dependent manner with VDR target genes in ROS17/2.8 osteosarcoma cells. A cyclic pattern of promoter occupancy by VDR, SRC-1, and NCoA62/SKIP was observed, with NCoA62/SKIP entering these promoter complexes after SRC-1. These studies provide strong support for the proposed role of NCoA62/SKIP as a VDR transcriptional coactivator, and they indicate that key mechanistic differences probably exist between NCoA62/SKIP and SRC coactivators. To explore potential mechanisms, NCoA62/SKIP-interacting proteins were purified from HeLa cell nuclear extracts and identified by mass spectrometry. The identified proteins represent components of the spliceosome as well as other nuclear matrix-associated proteins. Here, we show that a dominant negative inhibitor of NCoA62/SKIP (dnNCoA62/SKIP) interfered with appropriate splicing of transcripts derived from 1,25-dihydroxyvitamin D3-induced expression of a growth hormone minigene cassette. Taken together, these data show that NCoA62/SKIP has properties that are consistent with those of nuclear receptor coactivators and with RNA spliceosome components, thus suggesting a potential role for NCoA62/SKIP in coupling VDR-mediated transcription to RNA splicing.
Yang F, Fan J, Yang R, Cun Y Front Immunol. 2024; 15:1338162.
PMID: 38957470 PMC: 11217175. DOI: 10.3389/fimmu.2024.1338162.
Ahmad N, de la Serna I, Marathe H, Fan X, Dube P, Zhang S Life (Basel). 2023; 13(2).
PMID: 36836771 PMC: 9962273. DOI: 10.3390/life13020414.
Involucrin Modulates Vitamin D Receptor Activity in the Epidermis.
Schmidt A, Miciano C, Zheng Q, Mathyer M, Grice E, de Guzman Strong C J Invest Dermatol. 2023; 143(6):1052-1061.e3.
PMID: 36642403 PMC: 10240284. DOI: 10.1016/j.jid.2022.12.009.
MicroRNA-195-5p inhibits the progression of hemangioma via targeting SKI.
Sun B, Huang Z, Yang H, Zhao X Exp Ther Med. 2022; 23(2):165.
PMID: 35069846 PMC: 8753966. DOI: 10.3892/etm.2021.11088.
Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis.
Kumar R, Haider S IBRO Neurosci Rep. 2021; 12:25-44.
PMID: 34918006 PMC: 8669318. DOI: 10.1016/j.ibneur.2021.12.002.